In addition to the presented studies, we summarize in Table S17 the ongoing clinical trials with other strategies such as vaccines (including DC-vaccine [NCT04487756]), immune modulators (including bomedemstat, anti-LSD1 [NCT05191797], and radiation therapies (including TRIPLEX [CT05223647] and CHEST RT [NCT05796089] which are investigating chest radiotherapy in addition to CT + ICI, and RAPTOR [NCT04402788] investigating addition of radiotherapy on several tumor sites) [208]. The gene discussed is KDM1A; the disease is neoplasm.